Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: TAP Block With Lidocaine and Ropivacaine 0.2% (0.4 ml/kg/Side) for Pain and Opioid Reduction After Hysterectomy [NA]

View source ↗

Summary

Clinical trial update on TAP block using lidocaine and ropivacaine 0.2% (0.4 ml/kg per side) for postoperative pain control and opioid reduction after hysterect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)
  • Naropin (ropivacaine)

Snippet

Sponsor: Matild Keresztes | Conditions: Postoperative Pain Following Hysterectomy | NA | Status: ACTIVE_NOT_RECRUITING